SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 68 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 5.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,121,604 | +475.0% | 2,383,825 | +916.0% | 0.00% | – |
| Q3 2022 | $369,000 | -83.8% | 234,638 | -79.3% | 0.00% | -100.0% |
| Q2 2022 | $2,281,000 | -60.5% | 1,135,069 | -54.2% | 0.00% | -50.0% |
| Q1 2022 | $5,780,000 | +46.4% | 2,480,761 | +192.2% | 0.00% | +100.0% |
| Q4 2021 | $3,947,000 | +7.9% | 848,887 | +77.0% | 0.00% | 0.0% |
| Q3 2021 | $3,659,000 | +142.6% | 479,619 | +208.2% | 0.00% | – |
| Q2 2021 | $1,508,000 | -38.2% | 155,609 | -47.3% | 0.00% | -100.0% |
| Q1 2021 | $2,442,000 | +226.9% | 295,322 | +169.8% | 0.00% | – |
| Q4 2020 | $747,000 | -35.0% | 109,465 | +6.2% | 0.00% | – |
| Q3 2020 | $1,150,000 | +162.0% | 103,118 | +47.4% | 0.00% | – |
| Q2 2020 | $439,000 | +143.9% | 69,947 | -28.7% | 0.00% | – |
| Q1 2020 | $180,000 | -67.9% | 98,039 | -40.8% | 0.00% | – |
| Q4 2019 | $560,000 | +156.9% | 165,663 | +63.0% | 0.00% | – |
| Q3 2019 | $218,000 | +215.9% | 101,633 | +288.8% | 0.00% | – |
| Q2 2019 | $69,000 | -45.2% | 26,139 | -1.7% | 0.00% | – |
| Q1 2019 | $126,000 | -92.5% | 26,583 | -96.2% | 0.00% | -100.0% |
| Q4 2018 | $1,669,000 | +133.4% | 695,226 | +327.7% | 0.00% | – |
| Q3 2018 | $715,000 | +126.3% | 162,552 | +270.4% | 0.00% | – |
| Q2 2018 | $316,000 | -86.1% | 43,883 | -90.1% | 0.00% | -100.0% |
| Q1 2018 | $2,276,000 | +2486.4% | 442,058 | +1804.6% | 0.00% | – |
| Q4 2017 | $88,000 | +2833.3% | 23,210 | +1447.3% | 0.00% | – |
| Q3 2017 | $3,000 | -57.1% | 1,500 | -57.7% | 0.00% | – |
| Q2 2017 | $7,000 | -22.2% | 3,543 | +53.8% | 0.00% | – |
| Q1 2017 | $9,000 | -98.9% | 2,303 | -98.6% | 0.00% | – |
| Q4 2016 | $786,000 | -20.3% | 160,270 | +25.9% | 0.00% | -100.0% |
| Q3 2016 | $986,000 | +88.2% | 127,332 | +36.2% | 0.00% | – |
| Q2 2016 | $524,000 | +1397.1% | 93,517 | +1338.7% | 0.00% | – |
| Q1 2016 | $35,000 | -27.1% | 6,500 | +18.6% | 0.00% | – |
| Q4 2015 | $48,000 | -4.0% | 5,482 | -7.9% | 0.00% | – |
| Q3 2015 | $50,000 | +284.6% | 5,951 | +692.4% | 0.00% | – |
| Q2 2015 | $13,000 | -56.7% | 751 | -71.2% | 0.00% | – |
| Q1 2015 | $30,000 | +400.0% | 2,611 | +373.9% | 0.00% | – |
| Q4 2014 | $6,000 | – | 551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 6,000,000 | $66,900,000 | 2.57% |
| SABBY MANAGEMENT, LLC | 606,298 | $6,760,000 | 1.01% |
| Virtus ETF Advisers LLC | 66,851 | $745,000 | 0.39% |
| Newbridge Financial Services Group, Inc. | 26,900 | $300,000 | 0.30% |
| Avidian Wealth Solutions, LLC | 330,000 | $3,680,000 | 0.28% |
| Spectrum Wealth Advisory Group, LLC | 36,692 | $422,000 | 0.27% |
| COWEN AND COMPANY, LLC | 129,200 | $1,441,000 | 0.24% |
| Cormorant Asset Management, LP | 500,000 | $5,575,000 | 0.21% |
| SYMMETRY PEAK MANAGEMENT LLC | 27,500 | $307,000 | 0.20% |
| Aristides Capital LLC | 24,302 | $271,000 | 0.19% |